Learn About Abattis
Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal and adult marijuana markets in North America.
Abattis Bioceuticals Corp. (OTC: ATTBF)
Latest price $ 0.43 Volume 102079
(08-22-2014 16:14 EST)
Abattis Bioceuticals Corp. (CSE: ATT)
(Click here to view CSE quote)